Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer
about
Exercise after breast cancer treatment: current perspectivesHow do chemotherapeutic agents damage the ovary?Effects of Bushen Tianjing Recipe in a rat model of tripterygium glycoside-induced premature ovarian failureExercise for the management of side effects and quality of life among cancer survivors.Exercise Recommendations for the Management of Symptoms Clusters Resulting From Cancer and Cancer TreatmentsIncreased fracture rate in women with breast cancer: a review of the hidden risk.Amniotic fluid stem cells prevent follicle atresia and rescue fertility of mice with premature ovarian failure induced by chemotherapy.Chemotherapy-induced menopause: a literature review.Fertility preservation in women with cancer.Bone mineral density in women with cytotoxic-induced ovarian failure.Fertility preservation and management of gonadal failure associated with lymphoma therapy.Cisplatin and doxorubicin induce distinct mechanisms of ovarian follicle loss; imatinib provides selective protection only against cisplatinOsteoporosis in women with breast cancer.Adjuvant bisphosphonates in endocrine-responsive breast cancer: what is their place in therapy?Prevention and management of osteoporosis in women with breast cancer and men with prostate cancer.Safety of aromatase inhibitors in the adjuvant setting.Low Bone Mineral Density in Middle-Aged Breast Cancer Survivors: Prevalence and Associated Factors.Bisphosphonates' use in metastatic bone disease.Chemotherapy-Induced Amenorrhea - An UpdateRaloxifene reduces fractures in postmenopausal women with osteoporosis.A review of age differences in psychological adjustment to breast cancer.Skeletal complications of breast cancer therapiesExosomal miR-10a derived from amniotic fluid stem cells preserves ovarian follicles after chemotherapy.Exercise Recommendations for Cancer-Related Fatigue, Cognitive Impairment, Sleep problems, Depression, Pain, Anxiety, and Physical Dysfunction: A Review.Management of cancer treatment-induced bone loss in early breast and prostate cancer -- a consensus paper of the Belgian Bone Club.Adjuvant systemic therapy for early breast cancer.Bone mineral loss induced by anticancer treatment for gynecological malignancies in premenopausal women.Premature menopause in young breast cancer: effects on quality of life and treatment interventions.Zoledronic acid prevents bone loss in premenopausal women undergoing adjuvant chemotherapy for early-stage breast cancer.Adverse bone effects during pharmacological breast cancer therapy.Management of complications from estrogen deprivation in breast cancer patients.Current and emerging treatment strategies for breast cancer-induced bone loss.Impact + resistance training improves bone health and body composition in prematurely menopausal breast cancer survivors: a randomized controlled trial.Skeletal manifestations of treatment of breast cancer.Effects of hypogonadism on bone metabolism in female adolescents and young adults.A prospective model of care for breast cancer rehabilitation: bone health and arthralgias.Antiresorptive therapy in the management of cancer treatment-induced bone loss.Exercise for improving bone health in women treated for stages I-III breast cancer: a systematic review and meta-analyses.Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: a prospective study.Profiles of lipids, blood pressure and weight changes among premenopausal Chinese breast cancer patients after adjuvant chemotherapy.
P2860
Q26778893-9C4782C7-9023-44FC-AFA0-AC1C4317CD4CQ28267696-E835E044-12DA-40ED-85DE-DB2836FD02C1Q33594483-641CA752-22C8-4B51-86D6-1B0C40B4D066Q33871938-26DC44D5-3185-42EB-88D4-DB720788FA89Q33907387-DF1EBE78-F43F-4053-BA25-E0614160116EQ34004925-70957497-C9C8-42F2-B796-BB76152FB650Q34149813-0D87B54A-E357-443B-9833-3A37E658A167Q34326838-4236313D-6AC3-4D87-B0AC-B9CBB89A764DQ34729392-AEA32567-5996-428B-AAC3-A6806EAE3B9CQ34756056-27DB8BDA-DDC3-4E6A-8F3F-A1412075C639Q34774197-1AF57604-E020-475E-AB52-ED770AC4EAB8Q34905992-C70DC43B-EEB8-4B15-935D-EFFBDE33AA44Q35031054-861F9DCC-3A33-408F-B434-E303F1EDFDBFQ35076216-D39A9678-F8EA-458F-AE58-1E3BD761A9A5Q35783046-81E8DA4D-3FB8-41D8-979F-845FE8B6DAE3Q36026543-2A9234D8-F7C1-4D83-B1D2-C80F03FA8E5BQ36036113-CFE753D0-BC39-4B86-A5DD-FD388F33CF41Q36198384-B7810572-8C75-4992-A042-69FAC7BBDF99Q36295133-4F1E2C1B-A2CC-4C92-96E6-77C5FA4F2B26Q36389080-CAB30C95-E931-45AD-BD80-CC02EEB95FDAQ36402975-EE496462-8D68-4530-AF31-C4B44D54AAE7Q36633831-DF333CBD-CA8E-4D25-A83B-FFBF52404CB5Q36691028-15A3B3E0-BB78-4040-9905-7CB2B2193142Q36825401-B50B4C48-DDB2-4FFB-817A-F339288810F8Q36906736-7014A729-8035-4B95-8974-28AFB0E32C0EQ36923988-1BF8F1CA-C735-4D3F-BFF9-DA1E3E09DA91Q36924555-CA302801-3751-4FC5-996D-320E49770986Q36963345-3DAC8F79-833E-4A4C-8AB4-6334A087A703Q37121724-134D36B0-615B-40DA-85A0-9A497EE1BED2Q37157596-03383971-4C9B-4FF0-8944-4F99B069A15FQ37350187-68091086-5EAB-415A-A8AF-AB63418F26C9Q37355790-8AE15AB5-3FBF-4007-A38F-662A3A8F6D5FQ37376419-A99DFDF4-920E-4204-9098-309F72601E10Q37630298-E671C7D6-117D-4092-B4CB-336536B70773Q37978208-E0F1BF88-9DF5-4307-A85E-E84A25B4A18EQ38001377-4D332EFD-2581-4D8D-AEF8-52D86648E99FQ38313112-BB886240-6732-4B94-919B-FFA8D083ED77Q38714539-32757DF3-21A8-49C6-9445-75E4268A366CQ39861823-19A06424-0A64-438D-9614-040ECCEDF544Q41163292-34BFB83A-E770-4010-BEC3-BCBC3CCE874B
P2860
Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer
@ast
Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer
@en
type
label
Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer
@ast
Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer
@en
prefLabel
Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer
@ast
Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer
@en
P2093
P2860
P356
P1476
Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer
@en
P2093
Bruning PF
de Jong-Bakker M
van den Ende A
P2860
P2888
P304
P356
10.1038/BJC.1990.58
P407
P577
1990-02-01T00:00:00Z
P5875
P6179
1015146238